Trademark Search in Canada

MUNJOVI

View On IC.GC.CA

REGISTERED

on 1 Nov 2023

Last Applicant/ Owned by

INCYTE HOLDINGS CORPORATION

1801 Augustine Cut-OffWilmington DE 19803

Serial Number

2081974 filed on 19^th Oct 2020

Registration Number

TMA1205964 registered on 1^st Nov 2023

Registration expiry Date

19^th Oct 2030

Correspondent Address

LAVERY, DE BILLY, LLP

1 Place Ville Marie, Suite 4000Montréal

QUÉBEC

H3B4M4

MUNJOVI

Trademark usage description

pharmaceuticals and pharmaceutical preparations for human use for the treatment and prevention of cancer, restenosis and metabolic disorders, namely, Read More

Classification Information

Class [005]
Pharmaceuticals and pharmaceutical preparations for human use for the treatment and prevention of cancer, restenosis and metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, chronic obstructive pulmonary disease, inflammatory diseases of the thyroid, pelvic inflammatory disease, arthritis, asthma; Antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis and antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; diagnostic preparations for medical purposes diagnostic use; biological substances for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; clinical medical reagents, namely clinical diagnostic reagents; biological preparations for medical purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis.

Classification kind code

Class [042]
Scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis.

Classification kind code

Mark Details

Serial Number

2081974

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 2^th Jun 2022	Agent Changed
Submitted for opposition 22 on 25^th May 2022	Search Recorded
Submitted for opposition 20 on 25^th May 2022	Examiner's First Report
Submitted for opposition 223 on 25^th May 2022	Total Provisional Refusal
Submitted for opposition 256 on 6^th Dec 2021	Notification of Possible Opposition Sent
Submitted for opposition 257 on 4^th Feb 2021	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 3^rd Feb 2021	Created
Submitted for opposition 31 on 3^rd Feb 2021	Formalized
Submitted for opposition 30 on 19^th Oct 2020	Filed
Submitted for opposition 228 on 19^th Oct 2020	International Registration